Table 2. Data for 4 patients with NTM in 2 consecutive sputum samples and 3 NTM-positive patients from whom 1 of 2 sputum samples contained mycobacteria that could not be identified, Zambia, August 2002–March 2003*.

Patient no.	Isolate from first sputum sample	Isolate from second sputum sample	Ziehl-Neelsen staining	Sex	Age, y	HIV status	Temp, °C	Duration, wk	Chest radiograph result	Died	BMI
1†	Mycobacterium intracellulare	AFB not identified	1+	M	55	+	34.6	17	Suspected TB	Yes	17
2†	AFB not identified	M. intracellulare	–	F	45	+	36.1	487	Suspected TB	No	20
3	M. intracellulare	M. intracellulare	–	M	43	+	36.3	3	No pathologic changes	No	19
4†	M. intracellulare	M. intracellulare	–	M	32	+	36.8	17	Suspected TB	Yes	15
5	AFB not identified	M. porcinum	–	F	50	–	36.6	8	No suspected TB	No	21
6	M. avium	M. avium	–	M	33	+	37.4	17	No radiograph	No	16
7	M. avium	M. peregrinum, M. tuberculosis	–	F	24	+	35.0	13	No pathologic changes	Yes	NK

*NTM, nontuberculous mycobacteria; Temp, temperature at time of enrollment; Duration, duration of symptoms from time of coming to the hospital to enrollment in the study; BMI, body mass index; AFB, acid-fast bacilli; TB, tuberculosis; NK, not known. All patients had respiratory symptoms.
†Patients assumed to have pulmonary NTM disease.